{
    "success": true,
    "data": {
        "ucits": true,
        "type": "ETF",
        "replication_method": "synthetic",
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "leverage": false,
        "complex_factors": [
            "Synthetic Replication",
            "Embedded Derivatives (implied by synthetic replication)",
            "Difficult to understand risks (counterparty, collateral)"
        ],
        "classification": "complex",
        "supporting_data": "The product is described as 'Open End Tracker Certificates linked to UBS CMCI Composite USD TR Index'. The KIID explicitly states: 'You are about to purchase a product that is not simple and may be difficult to understand.' Furthermore, it mentions the investor may bear losses up to the total loss of capital invested and attaches no importance to capital protection. The 'Risk Indicator' is rated '4 out of 7, which is a medium risk class', but the text also states that 'poor market conditions are very unlikely to impact our capacity to pay you', which hints at counterparty risk. The lack of capital protection means investors bear full market risk, which is standard for equity ETFs. The fact that it's a 'tracker certificate' implies a derivative-based replication method (synthetic replication) rather than physical holding of assets, which introduces complexities like counterparty risk and collateral risk, as per MiFID II rules and ESMA guidelines. Even if the index itself is transparent, the underlying replication mechanism using derivatives makes it complex for a retail investor.  The KIID also includes a comprehension alert: 'You are about to purchase a product that is not simple and may be difficult to understand.'"
    }
}